Stockreport

Edesa Biotech Reports Final Phase 2b Results for Dermatitis Study [Yahoo! Finance]

Edesa Biotech, Inc. - Common Shares  (EDSA) 
PDF TORONTO, ON / ACCESSWIRE / November 20, 2023 / Edesa Biotech, Inc. (NASDAQ:EDSA), a clinical-stage biopharmaceutical company focused on inflammatory and immune-related [Read more]